Status:

COMPLETED

Characterization of the Incretinpathy in Type 2 Diabetes Initiated After Sixty Years Old

Lead Sponsor:

University of Campinas, Brazil

Conditions:

Diabetes Mellitus, Type 2

Insulin Resistance

Eligibility:

All Genders

35-80 years

Brief Summary

Type 2 diabetes (T2DM) is characterized by hyperglycemia, insulin resistance, absolute or relative insulin deficiency, hyperglucagonemia, increased hepatic glucose production, frequently accelerated g...

Eligibility Criteria

Inclusion

  • Stable weight (\<5% variation) within the last three months
  • Age: 35 to 50 years old for middle-age group, and 65 to 80 y old for elderly group
  • Body mass index (BMI): 20 to 29.9kg/m2
  • T2DM with diagnosis above 35 years and less than 5 years (Middle-age group)
  • T2DM with diagnosis above 65 years and less than 5 years (Elderly group)
  • Use of oral antidiabetic drugs (that must at stable dose within the last 3 months)
  • Not have participated in any study of intervention with drugs in the last six months.

Exclusion

  • Use of estrogen, progestogen, active antipsychotics and systemic corticosteroids
  • Use of DPP-IV inhibitors and incretin mimetics (current or within 1 month before)
  • Continuous use of insulin or glitazone
  • Hepatic cirrhosis, renal failure or any clinical condition with impaired insulin sensitivity
  • Smoking
  • Obesity
  • Uncontrolled systemic or disabling diseases
  • T2DM treated by non pharmacological methods
  • Patients submitted to bariatric surgery
  • Latent autoimmune diabetes of the adult (positive anti-GAD antibodies)

Key Trial Info

Start Date :

July 1 2009

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 1 2010

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT00843232

Start Date

July 1 2009

End Date

September 1 2010

Last Update

February 4 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

LIMED (Laboratory of Investigation of Metabolism and Diabetes)/GASTROCENTRO/Univeristy of Campinas (UNICAMP)

Campinas, São Paulo, Brazil